HB1954Introduced in the House
AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine products.
Introduced by Esther Helton-Haynes, District 30
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.
Where it stands
Comp. became Pub. Ch. 677
April 13, 2026
How did lawmakers vote?
HouseStage: FLOOR VOTE: CONSENT CALENDAR PASSAGE ON THIRD CONSIDERATION · March 23, 2026
82
Yes
0
No
2
Absent or Not Voting
84 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.
See how each representative voted
| Representative | District | Vote |
|---|---|---|
| John Crawford | 1 | Yes |
| Bud Hulsey | 2 | Yes |
| Timothy Hill | 3 | Yes |
| Renea Jones | 4 | Yes |
| David Hawk | 5 | Yes |
| Tim Hicks | 6 | Yes |
| Rebecca Alexander | 7 | Yes |
| Jerome Moon | 8 | Yes |
| Gary Hicks | 9 | Yes |
| Rick Eldridge | 10 | Yes |
Bill history
Filed for introduction
Intro., P1C.
P2C, ref. to Health Committee
Assigned to s/c Health Subcommittee
Placed on s/c cal Health Subcommittee for 2/18/2026
Rec. for pass by s/c ref. to Health Committee
Placed on cal. Health Committee for 3/3/2026
Action def. in Health Committee to 3/10/2026
Placed on cal. Health Committee for 3/10/2026
No Action Taken
Placed on cal. Health Committee for 3/17/2026
Rec. for pass; ref to Calendar & Rules Committee
Placed on cal. Calendar & Rules Committee for 3/19/2026
H. Placed on Consent Calendar for 3/23/2026
Comp. SB subst.
Comp. became Pub. Ch. 677
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.